Innovation in Sequencing and Proteomics with BGI – Comprehensive Solutions for Biomedical Research
Biomol, in collaboration with BGI Genomics, offers research centers, hospitals, and biotechnology companies a comprehensive portfolio of next-generation sequencing, multi-omics analysis, and proteomics services. The aim of this partnership is to streamline communication and logistics—facilitating both sample preparation and shipment—so that scientific teams can focus on what matters most: generating knowledge.
Powered by proprietary DNBSEQ™ technology, these solutions deliver high accuracy, low error rates, and scalability, tailored to projects of any size. BGI’s global track record—millions of samples processed across more than 100 countries and international certifications (CAP, CLIA, CE-IVD)—underpins the robustness of these services.
Broad Portfolio of Services
The collaboration between Biomol and BGI Genomics provides an end-to-end offering that spans DNA and RNA sequencing through to advanced protein and metabolite analysis, with bioinformatics support and technical guidance at every stage of the project.
This offering is structured into two complementary lines:
- Clinical solutions, focused on genetic diagnostics and personalized medicine.
- Technology solutions, designed for genomic, transcriptomic, epigenomic, proteomic, and multi-omic research.
1) Clinical Solutions
Biomol and BGI’s clinical solutions are designed to support personalized medicine, combining high-quality next-generation sequencing with advanced bioinformatics.
Key areas:
- Reproductive health: carrier screening, prenatal screening, and preimplantation genetic testing.
- Molecular oncology: hereditary cancer panels, tumor genomic profiling, and therapy guidance.
- Infectious diseases: pathogen identification via metagenomic sequencing (PMseq) or targeted sequencing (PTseq).
- Clinical genetics: whole-exome studies, genotyping, and variant analysis related to chronic or rare diseases.
These solutions apply next-generation sequencing (NGS) to clinical practice, enabling early diagnosis, patient stratification, and more precise therapeutic decision-making.
2) Technology Solutions
BGI offers one of the world’s most extensive infrastructures for sequencing, proteomics, and multi-omics analysis, covering all stages of the experimental workflow—from extraction to advanced data analysis.
Sequencing services
- Genomics and exome: whole genome resequencing, de novo sequencing, bisulfite sequencing, ChIP-seq, exome capture.
- Transcriptomics (RNA-seq): mRNA, long non-coding RNA, small RNA, isoform sequencing, and strand-specific studies.
- Metagenomics and microbiome: microbial characterization via 16S/18S/ITS and shotgun metagenomics.
- Epigenomics: methylation and gene regulation analyses.
- Single-cell and spatial omics: cellular and spatial resolution for transcriptomics and epigenetics.
Proteomics and metabolomics
Proteomics, based on mass spectrometry, enables the simultaneous quantification and characterization of thousands of proteins, identification of post-translational modifications (PTMs), and analysis of functional networks.
Services include:
- Quantitative proteomics (label-free, DIA, TMT).
- Targeted proteomics and nanoproteomics.
- Multi-omics integration: combining proteomics with transcriptomics and metabolomics to deliver a comprehensive view of biological processes.
Proteomics is a cornerstone of the offering. It enables the characterization of protein expression, abundance, interactions, and modifications in organisms, tissues, or cells.
Combined with genomic and transcriptomic data, proteomics provides an integrated biological map that advances:
- Personalized medicine
- Molecular oncology
- Rare diseases
- Neuroscience
- Human and environmental microbiome
- Developmental biology
- Pharmacogenomics
Bioinformatics Analysis and Data Visualization
All services are supported by specialized bioinformatics platforms and interpretation tools such as Dr. Tom, enabling researchers to access clear, comparative, publication-ready results.
BGI’s analysis teams provide support in alignment, quantification, variant detection, differential analysis, and functional enrichment, ensuring maximum data traceability.
Key Benefits Offered by BGI
- High accuracy and low duplication rates.
- International certifications: CAP, CLIA, CE-IVD.
- Cost optimization and scalability for projects large and small.
- End-to-end technical support: experimental design, extraction, sequencing, and bioinformatics analysis.
- Broad application range: projects in humans, animals, plants, and microorganisms.
- Diversified technological infrastructure: genomics, transcriptomics, epigenomics, proteomics, and metabolomics.
A Strategic Partner at Every Stage
Biomol positions itself as a strategic ally throughout all phases of the project. From study design to delivery of results, we provide continuous, personalized support.
By integrating genomics, transcriptomics, epigenomics, proteomics, and metabolomics, we enable a holistic understanding of biological processes—driving the discovery of new biomarkers, innovative therapies, and diagnostic tools.
Our shared commitment is to deliver high-quality scientific solutions that propel progress in basic, applied, and translational research.
